Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity

  • Authors:
    • Yehong Kuang
    • Shouman Wang
    • Lili Tang
    • Jian Hai
    • Guojiao Yan
    • Liqiu Liao
  • View Affiliations

  • Published online on: March 7, 2018     https://doi.org/10.3892/ol.2018.8199
  • Pages: 7279-7290
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Vacuolar H+‑ATPase (V‑ATPase) serves a key role in adjusting and maintaining the intracellular pH, as well as in regulating the drug resistance of tumor cells. In recent years, the expression level of V‑ATPase has been considered to be able to predict the sensitivity of breast cancer cells to chemotherapy drugs. Cluster of differentiation 147 (CD147) is known to serve a key role in the development and progression of breast cancer. The present study aimed to identify the role CD147 and V‑ATPase in chemoresistance in breast cancer, and to characterize the regulation of CD147 on V‑ATPase. Firstly, the expression levels of CD147 and V‑ATPase were detected in chemotherapy‑resistance breast cancer samples. It was demonstrated that V‑ATPase was highly expressed in chemotherapy‑resistance breast cancer samples, and that its expression was correlated with CD147 expression. Subsequently, MCF‑7 and MDA‑MB‑231 cells were used to study the regulatory effect of CD147 on the expression and function of V‑ATPase. Gene transfection or small interfering RNA transfection were used to control the expression of CD147 in the two cell lines. The results revealed that the overexpression of CD147 increased the expression of V‑ATPase in MCF‑7 cells, whereas CD147 knockdown decreased V‑ATPase expression in MDA‑MB‑231 cells. It was also observed that CD147 affected the V‑ATPase activity, regulating the transmembrane pH gradient of cancer cells. These results demonstrated that CD147 was associated with the sensitivity of chemotherapeutic drugs of epirubicin and docetaxel, while pantoprazole was able to partially reverse the CD147‑mediated chemoresistance in breast cancer. Therefore, the current study provided a possible mechanism for further examination of drug resistance in breast cancer.
View Figures
View References

Related Articles

Journal Cover

May-2018
Volume 15 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kuang Y, Wang S, Tang L, Hai J, Yan G and Liao L: Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity. Oncol Lett 15: 7279-7290, 2018.
APA
Kuang, Y., Wang, S., Tang, L., Hai, J., Yan, G., & Liao, L. (2018). Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity. Oncology Letters, 15, 7279-7290. https://doi.org/10.3892/ol.2018.8199
MLA
Kuang, Y., Wang, S., Tang, L., Hai, J., Yan, G., Liao, L."Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity". Oncology Letters 15.5 (2018): 7279-7290.
Chicago
Kuang, Y., Wang, S., Tang, L., Hai, J., Yan, G., Liao, L."Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity". Oncology Letters 15, no. 5 (2018): 7279-7290. https://doi.org/10.3892/ol.2018.8199